eMedI Chat 
eMedI Chat
eMedI Chat 
WHAT IS I’M IN?
I’M IN is a unique first-of-its-kind initiative developed by EMD Serono, Inc. to foster a robust community of healthcare professionals who actively address disparities in healthcare.
Our goal is to create exponential change in our healthcare ecosystem.
Our initiative does this through impact-oriented educational programs that raise awareness, elevate diverse perspectives, and drive conversations about how to weave diversity, equity, and inclusion into the fabric of our healthcare ecosystem.
Why I’M IN?
The I’M IN Initiative represents a novel and meaningful way for HCPs to engage and learn from themselves and from others.
I had the honor of participating in the inaugural session held in September, 2020. I gained valuable insights on diversity, equity, and inclusion while also realizing my own vulnerabilities. There is humility in learning, and this initiative has spurred me in the right direction.
Dr. Ravi Dukkipati, Wellspan Neurosciences
US-NONNI-01855. 02/2024.
Gretchen Terry-Leonard
Director of Strategic Alliances
Gretchen.Terry-Leonard@EMDSerono.com
2023 GLOBAL HEALTHCARE
DEI AWARD: HEALTH EQUITY
The I’M IN program has been honored by Merck KGaA, Darmstadt, Germany for their work advancing health equity.
IMPACTFUL
INNOVATION
THROUGH
EDUCATION
- Mastering the Neuroscience of Unconscious Bias in MS Care
- Fertility Family Planning & MS
- Addressing the Underserved Patient Population
- Authentic Leadership in Medicine
- Insights on Addressing Health Disparities in Research & Healthcare in MS
- Serving the LGBTQIA+ Patient Population in Research and Healthcare
- Women in Neurology - Shaping the Future of Research and Healthcare
- How to Drive Innovation in MS Patient Care
- Are We Asking the Right Questions About Family Planning for People Living with MS?
- Unleashing Potential: Transformational Leadership and Neuro Resilience
I’M IN HEALTH
EQUITY FELLOWSHIPS
EMD Serono’s Medical Affairs Team funds first-of-their-kind national fellowships dedicated to reducing patient care disparities. These fellowships, which initiated in neurology in 2022, have expanded to additional therapeutic areas - oncology and fertility - and additional institutions in the past two years.
This site is intended for US healthcare professionals only.
DISCLAIMER: This site contains medical information that is intended for healthcare providers of the United States only. The medical information contained on this site is not meant to substitute for the advice provided by a medical professional. Canadian residents should consult the EMD Serono Canada Inc. website at www.emdserono.ca for information on products and services approved in Canada. Use and access of this site is subject to the terms and conditions as set out in our Legal Statement and Privacy Policy.
EMD Serono is the Healthcare business of Merck KGaA, Darmstadt, Germany, in the United States and Canada.
US-MULNP-00046 1/26
© 2026 Merck KGaA, Darmstadt, Germany or its affiliates. All rights reserved.